National Health Investors (NYSE:NHI) Upgraded to Buy by StockNews.com

StockNews.com upgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning.

Other equities analysts have also issued reports about the stock. BMO Capital Markets raised shares of National Health Investors from a market perform rating to an outperform rating and set a $67.00 price objective on the stock in a report on Tuesday, March 12th. Deutsche Bank Aktiengesellschaft started coverage on shares of National Health Investors in a report on Tuesday, January 30th. They set a buy rating and a $69.00 price objective on the stock. Truist Financial lifted their price objective on shares of National Health Investors from $55.00 to $58.00 and gave the company a hold rating in a report on Thursday, April 4th. Wells Fargo & Company raised shares of National Health Investors from an equal weight rating to an overweight rating and lifted their price objective for the company from $55.00 to $63.00 in a report on Monday, February 26th. Finally, Wedbush lifted their price objective on shares of National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a report on Monday, March 18th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus target price of $60.50.

National Health Investors Stock Performance

Shares of NYSE:NHI opened at $58.35 on Wednesday. The firm has a market cap of $2.53 billion, a PE ratio of 18.64 and a beta of 0.95. The firm’s 50 day simple moving average is $57.84 and its 200-day simple moving average is $54.93. National Health Investors has a one year low of $47.54 and a one year high of $62.93. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th will be paid a $0.90 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 annualized dividend and a yield of 6.17%. National Health Investors’s dividend payout ratio (DPR) is 115.02%.

Insider Buying and Selling at National Health Investors

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The stock was acquired at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares of the company’s stock, valued at approximately $6,466,757.65. The purchase was disclosed in a document filed with the SEC, which is available through this link. 8.21% of the stock is owned by insiders.

Institutional Investors Weigh In On National Health Investors

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Pensionfund Sabic lifted its stake in shares of National Health Investors by 13.3% during the first quarter. Pensionfund Sabic now owns 17,000 shares of the real estate investment trust’s stock worth $1,068,000 after buying an additional 2,000 shares during the period. Compass Wealth Management LLC acquired a new position in National Health Investors during the first quarter valued at $30,000. Pensionfund DSM Netherlands lifted its position in National Health Investors by 5.6% during the first quarter. Pensionfund DSM Netherlands now owns 37,600 shares of the real estate investment trust’s stock valued at $2,362,000 after purchasing an additional 2,000 shares during the period. PNC Financial Services Group Inc. lifted its position in National Health Investors by 6.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,979 shares of the real estate investment trust’s stock valued at $222,000 after purchasing an additional 238 shares during the period. Finally, Goldman Sachs Group Inc. lifted its position in National Health Investors by 21.5% during the fourth quarter. Goldman Sachs Group Inc. now owns 118,464 shares of the real estate investment trust’s stock valued at $6,616,000 after purchasing an additional 20,971 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.